Characteristic | No. of Patients | Percentage | |
---|---|---|---|
Age (Years) | |||
Median | 50 | ||
Range | 18–83 | ||
Sex | |||
Male | 1099 | 65.5 | |
Females | 578 | 34.5 | |
Primary Tumor | |||
Head and Neck | 384 | 22.9 | |
Lung | 373 | 22.2 | |
Gastric | 191 | 11.4 | |
Lymphoma | 191 | 11.4 | |
Cervical | 121 | 7.2 | |
Testicular | 104 | 6.2 | |
Bladder | 77 | 4.6 | |
Sarcoma | 45 | 2.7 | |
Esophageal | 33 | 2.0 | |
Others | 158 | 9.4 | |
Khorana Risk Score | |||
Low | 350 | 20.9 | |
Intermediate | 1075 | 64.1 | |
High | 252 | 15.0 | |
Central Venous Catheter | |||
Present | 303 | 18.1% | |
Absent | 1374 | 81.9% | |
Disease Stage | |||
I | 56 | 3.3 | |
II | 213 | 12.7 | |
III | 487 | 29.0 | |
IV | 857 | 51.1 | |
Unstageable/Unknown | 64 | 3.8 |